208
Participants
Start Date
September 14, 2018
Primary Completion Date
February 15, 2023
Study Completion Date
February 15, 2023
Bortezomib Injection
Bortezomib: patients with BM relapsed, add for 4 doses on D1,4,7, 11 in induction; dosage 1.3 mg/m2/dose as per parenteral;
rituximab injection
Add rituximab in patients with CD20 positive ALL, rituximab: 6 doses of on D8,11of induction, D1,15 of consolidation1 and 2 with dosage 375 mg/m2 as parenteral (Terminated in Oct 2020)
Hong Kong Children's Hospital, Hong Kong
Shanghai Children's Medical Center
OTHER
Chinese University of Hong Kong
OTHER